A detailed history of Acadian Asset Management LLC transactions in Champions Oncology, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 30,697 shares of CSBR stock, worth $242,813. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,697
Previous 30,697 -0.0%
Holding current value
$242,813
Previous $157,000 5.73%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023

SELL
$4.11 - $6.81 $3,201 - $5,304
-779 Reduced 2.47%
30,697 $191,000
Q3 2021

Nov 12, 2021

SELL
$9.11 - $10.96 $9 - $10
-1 Reduced -0.0%
31,476 $320,000
Q1 2021

May 11, 2021

BUY
$10.61 - $13.75 $42,970 - $55,687
4,050 Added 14.77%
31,477 $356,000
Q4 2020

Feb 11, 2021

BUY
$8.39 - $13.27 $17,979 - $28,437
2,143 Added 8.48%
27,427 $295,000
Q3 2020

Nov 09, 2020

BUY
$7.05 - $10.2 $33,854 - $48,980
4,802 Added 23.44%
25,284 $233,000
Q2 2020

Aug 12, 2020

BUY
$6.65 - $9.84 $14,523 - $21,490
2,184 Added 11.94%
20,482 $196,000
Q4 2019

Feb 06, 2020

SELL
$5.12 - $8.33 $171,929 - $279,721
-33,580 Reduced 64.73%
18,298 $152,000
Q3 2019

Nov 07, 2019

SELL
$5.4 - $8.99 $370,477 - $616,776
-68,607 Reduced 56.94%
51,878 $293,000
Q2 2019

Aug 08, 2019

BUY
$7.51 - $10.12 $9,500 - $12,801
1,265 Added 1.06%
120,485 $944,000
Q1 2019

May 09, 2019

BUY
$7.89 - $12.23 $95,050 - $147,334
12,047 Added 11.24%
119,220 $1.17 Million
Q4 2018

Feb 07, 2019

BUY
$7.29 - $15.27 $260,172 - $544,971
35,689 Added 49.93%
107,173 $836,000
Q3 2018

Oct 30, 2018

BUY
$5.82 - $17.47 $416,036 - $1.25 Million
71,484 New
71,484 $1.25 Million
Q4 2017

Jan 18, 2018

SELL
$3.17 - $4.16 $3,100 - $4,068
-978 Closed
0 $0
Q3 2017

Oct 13, 2017

BUY
$3.03 - $3.97 $2,963 - $3,882
978
978 $4,000

Others Institutions Holding CSBR

About CHAMPIONS ONCOLOGY, INC.


  • Ticker CSBR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,522,400
  • Market Cap $107M
  • Description
  • Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...
More about CSBR
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.